SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-087607
Filing Date
2021-06-30
Accepted
2021-06-30 16:25:18
Documents
16
Period of Report
2021-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2120854d2_8k.htm   iXBRL 8-K 32790
2 EXHIBIT 1.1 tm2120854d2_ex1-1.htm EX-1.1 226015
3 EXHIBIT 5.1 tm2120854d2_ex5-1.htm EX-5.1 10205
7 GRAPHIC tm2120854d2_ex5-1img002.jpg GRAPHIC 1944
8 GRAPHIC tm2120854d2_ex5-1img001.jpg GRAPHIC 7969
  Complete submission text file 0001104659-21-087607.txt   519423

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA catb-20210630.xsd EX-101.SCH 3191
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE catb-20210630_lab.xml EX-101.LAB 34593
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE catb-20210630_pre.xml EX-101.PRE 22714
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2120854d2_8k_htm.xml XML 3693
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 211062221
SIC: 2834 Pharmaceutical Preparations